ADMA Biologics Inc (NASDAQ:ADMA)

9.54
Delayed Data
As of Feb 27
 -0.04 / -0.42%
Today’s Change
6.76
Today|||52-Week Range
14.00
-14.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
Revenue and IncomeNet Revenues761.0K1.1M3.1M--
 
 
 
 
Cost of Goods Sold1.8M487.0K4.2M--
 
 
 
 
Depreciation And Amortization219.6K182.1K210.6K--
 
 
 
 
 
Operating ExpensesGross Income-1.3M449.1K-1.4M--
 
 
 
 
General Expenses1.4M8.4M13.7M--
 
 
 
 
Research And Development0.003.5M9.3M--
 
 
 
Total Operating Expenses3.4M9.0M18.1M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-7.9M-15.0M--
 
 
 
 
Extraordinary Credit--0.0043.3K--
 
 
Interest Expense On Debt1.6M30.7K618.2K--
 
 
 
 
Other Expenses-1.9M0.0082.5K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M-7.9M-15.5M--
 
 
 
 
Income Taxes-320.8K-617.6K0.00--
 
 
 
Net Income-5.9M-7.3M-15.5M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS353.1K4.1M6.5M--
 
 
 
 
Shares To Calculate EPS Diluted353.1K4.1M6.5M--
 
 
 
 
 
Earnings Per ShareEPS-$16.72-$1.76-$2.38--
 
 
 
 
EPS Diluted-$16.72-$1.76-$2.38--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account